Intelligent Investor
Sign up for free Sign up for free Sign up for free

Cambium Bio Limited (ASX: CMB) - Share Price and Research

- Current share price for CMB : $0.400

Cambium Bio Limited (CMB), an ASX-listed company, is a Sydney-based clinical-stage regenerative medicine company focusing on the development of innovative biologics for ophthalmology and tissue repair applications. The Company's proprietary technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology.

CMB General Information +

ASX Code CMB
Website http://www.cambium.bio
Industry/Sector Biotechnology
Market Cap ($M) 7
CMB Share Price $0.400
Day High $0.410
Day Low $0.400
Last Close $0.400
CMB Share Price Movement - ( No change )
Prices as at 16:40, 13 Aug 2025
+Security prices are delayed by at least 20 minutes and are indicative only.
Upsell Banner

CMB Related Research

Cambium Bio Limited (CMB) Upcoming Dividends & Yields

There are no dividends for Cambium Bio Limited (CMB). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Cambium Bio Limited (CMB) price-sensitive announcements

CMB - Quarterly Activities/Appendix 4C Cash Flow Report
Cambium Bio Limited (CMB) provided its Quarterly Activities and Appendix 4C Cash Flow Repo
Cambium Bio Limited (CMB)
31 Jul 2025 | 11:39 AM
CMB - Cambium Bio Raises A$2.12 million
Cambium Bio Limited, an Australian biotechnology company, announced on 28 June 2024 that i
Cambium Bio Limited (CMB)
30 Jul 2025 | 11:14 AM
CMB - Quarterly Activities/Appendix 4C Cash Flow Report
Cambium Bio Limited reported significant progress in its clinical development of Elate Ocu
Cambium Bio Limited (CMB)
28 Apr 2025 | 9:55 AM
CMB - Half Year Report and Accounts
The Half-Year Report for Cambium Bio Limited for the period ending December 31, 2024, reve
Cambium Bio Limited (CMB)
27 Feb 2025 | 6:25 PM

See more price-sensitive ASX announcements or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

Cambium Bio Limited (CMB) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Cambium Bio Limited (CMB)
ORDINARY FULLY PAID
Health Care $7 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2025 11:39AM $0.460 $0.400 fallen by 13.04%
Cambium Bio Limited (CMB)
ORDINARY FULLY PAID
Health Care $7 Proposed issue of securities - CMB 30 Jul 2025 11:14AM $0.290 $0.400 risen by 37.93%
Cambium Bio Limited (CMB)
ORDINARY FULLY PAID
Health Care $7 Cambium Bio Raises A$2.12 million 30 Jul 2025 11:14AM $0.290 $0.400 risen by 37.93%
Cambium Bio Limited (CMB)
ORDINARY FULLY PAID
Health Care $7 Cambium Bio Clears FDA Regulatory Hurdles 11 Jul 2025 9:10AM $0.215 $0.400 risen by 86.05%
Cambium Bio Limited (CMB)
ORDINARY FULLY PAID
Health Care $7 Cambium Bio Receives Ethics Approvals 30 Jun 2025 9:23AM $0.210 $0.400 risen by 90.48%
Cambium Bio Limited (CMB)
ORDINARY FULLY PAID
Health Care $7 Change of Address 23 May 2025 3:56PM $0.190 $0.400 risen by 110.53%

CMB Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2024A -$1.96 -$47.10 4,257.40% 0.00 0.00 0.00% 0.0%
2023A -$3.30 -$1.10 -22.30% 0.00 0.00 0.00% 0.0%
2022A -$4.25 -$1.40 -295.80% 0.00 0.00 0.00% 0.0%

CMB Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2022 A 2023 A 2024 A 2022 A 2023 A 2024 A 2022 A 2023 A 2024 A
Cambium Bio Limited (CMB) $7M 42.5741 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
CSL Limited (CSL) $127,745M 0.2288 -0.2034 0.1108 31.4229 39.4479 35.5146 1.51% 1.11% 1.24%
Mesoblast Limited (MSB) $2,931M -0.3176 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Opthea Limited (OPT) $739M 0.2355 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Telix Pharmaceuticals Limited (TLX) $5,716M 9.9840 2.0833 1.6348 81.7918 26.5274 10.0680 0.00% 0.00% 0.00%

CMB Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.72 0.00
Market 0.23 13.80 1.12 0.73
Sector 1.00 17.50 2.35 0.69

CMB Directors

Name Position Start Date
Dr Edmund Waller Chief Scientific Officer, Executive Director, Executive Chairman 5 Apr 2024
Mr Terence A Walts Executive Director 5 Apr 2024
Dr Yu-Hung Sebastian Tseng Non-Executive Director 11 Apr 2024
Dr ChiTai Chang Non-Executive Director 10 Oct 2024
Professor Chandra Bala Non-Executive Director 22 Nov 2024
Mr Li Chien Chiu Non-Executive Director 7 Mar 2025
Dr Denese Marks Non-Executive Director 21 May 2025

Cambium Bio Limited (CMB) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
12 Mar 2025 TSENG, Yu-Hung Issued Direct Shares 215,657 $2.761 $595,479.000
12 Mar 2025 BALA, Chandra Issued Direct Shares 50,000 $0.464 $23,185.000
12 Mar 2025 WALTS, Terence Issued Direct Shares 50,000 $0.464 $23,185.000

See all changes in directors' interest & trades for Cambium Bio Limited (CMB) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

CMB Management

Name Position
Mark Andrew Licciardo Company Secretary

CMB Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (CMB). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
2,688,506 (0.23%) Zheng Yang Biomedical Technology Co Ltd
2,384,359 (0.20%) Cyntec Co Ltd
999,002 (0.08%) Treasure Century Group Limited
691,580 (0.06%) Apex Metro Investments Limited

CMB Calendar of Events

Date Event
26 February 2026 Report (Interim)
29 August 2025 Report (Annual)
29 August 2025 Report (Prelim)

FAQs about Cambium Bio Limited (CMB)

Cambium Bio Limited's (CMB) current share price is $0.40. This constitutes a price movement of 5.88% when compared to the share price 7 days ago and is -38.46% below CMB's 12-month high of $0.65 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $0.40, Cambium Bio Limited's (CMB) current share price of $0.40 constitutes a movement of or 0%. Cambium Bio Limited's (CMB) share price movement is -5.88% when compared to 7 days ago and is -38.46% below CMB's 52-week high of $0.65.

Cambium Bio Limited's (CMB) 52-week high is $0.65 which was reached on 29 Nov 2024. Relative to this, CMB's current share price of $0.40 constitutes a -$0.25 or -38.46% drop since that high of $0.65 per CMB share.

Cambium Bio Limited's (CMB) 52-week low is $0.19 which was reached on 8 May 2025. Relative to this, CMB's current share price of $0.40 constitutes a $0.21 or 110.53% gain since that low of $0.19 per CMB share.

Over the last 12 months, Cambium Bio Limited (CMB) has a daily average trading volume of 8,077 CMB shares per day.

Cambium Bio Limited (CMB) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for CMB is a ratio that tells you the percentage of Cambium Bio Limited's (CMB) share price that it pays out in dividends each year.

Cambium Bio Limited (CMB) will release its next Annual Report on 29 August 2025. Cambium Bio Limited's (CMB) last annual report was released on 30 Aug 2024. Click here to view Cambium Bio Limited's (CMB) last annual report.

Cambium Bio Limited (CMB) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Sigma Healthcare Limited (SIG), Pro Medicus Limited (PME), and ResMed Inc. (RMD).

The price-to-earnings (P/E) ratio for Cambium Bio Limited (CMB) is 0. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Cambium Bio Limited's (CMB) share price to its earnings per CMB share.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.